OVER 28 YEARS EXPERIENCE
Improving Lives with Precision Diagnostics®
OVER 28 YEARS EXPERIENCE
Improving Lives with
Precision Diagnostics®
INDUSTRY PIONEERS
We are the foremost experts in providing molecular products and services for oncology testing.
Invivoscribe offers a full range of oncology testing products and services (B- and T-cell clonality, NGS gene panels, MRD assays, and comprehensive bioinformatics software), all developed under ISO 13485 design control and manufactured in our cGMP facility.
MESSAGE FROM THE CEO
Dear Colleagues:
As in years past, I am taking this opportunity to highlight a few of our company’s many accomplishments in 2021 and identify a few of the many projects we will address in the coming year.
INDUSTRY PIONEERS
We are the foremost experts in providing molecular products and services for oncology testing.
Invivoscribe offers a full range of oncology testing products and services (B- and T-cell clonality, NGS gene panels, MRD assays, and comprehensive bioinformatics software), all developed under ISO 13485 design control and manufactured in our cGMP facility.


As a leading industry pioneer in the molecular diagnostic field, we are dedicated to improving the standard of healthcare worldwide.
We offer clinical laboratories, pharmaceutical companies, physicians, patients, and researchers high quality, reliable, and innovative molecular diagnostic solutions. These solutions range from CDx biomarker identification and patient stratification to assay development and reagent manufacturing, to the commercialization of these assays either as services at our harmonized clinical laboratories or as kits available to laboratories in over 160 countries.

As a leading industry pioneer in the molecular diagnostic field, we are dedicated to improving the standard of healthcare worldwide.
We offer clinical laboratories, pharmaceutical companies, physicians, patients, and researchers high quality, reliable, and innovative molecular diagnostic solutions. These solutions range from CDx biomarker identification and patient stratification to assay development and reagent manufacturing, to the commercialization of these assays either as services at our harmonized clinical laboratories or as kits available to laboratories in over 160 countries.

We strive to unlock and make accessible, the full potential of personalized molecular medicine, as we know the molecular basis behind each person’s disease is different.
As a reagent manufacturer, we offer a comprehensive selection of gel, capillary, and next-generation sequencing PCR assays for gene rearrangement, chromosome translocation, and gene mutation detection. These products are available through our global distribution network and are currently used in over 700 laboratories.

We strive to unlock and make accessible, the full potential of personalized molecular medicine, as we know the molecular basis behind each person’s disease is different.
As a reagent manufacturer, we offer a comprehensive selection of gel, capillary, and next-generation sequencing PCR assays for gene rearrangement, chromosome translocation, and gene mutation detection. These products are available through our global distribution network and are currently used in over 700 laboratories.
CONNECT
Invivoscribe Newsroom
The Latest Publications, News, Articles and Press Releases
CONNECT
Invivoscribe Newsroom
The Latest News, Articles, and Press Releases from Invivoscribe